Athyrium Capital Management, LP Portfolio Holdings

Athyrium Capital Management, LP

  • $3.2 Million
  • Q3 2024

Athyrium Capital Management, LP has filed its 13F form on November 12, 2024 for Q3 2024 where it was disclosed a total value porftolio of $3.2 Million distributed in 2 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Puma Biotechnology, Inc. with a value of $3.2M and Biora Therapeutics Inc. with a value of $0.

Examining the 13F form we can see an decrease of $892K in the current position value, from $4.1M to 3.2M.

Athyrium Capital Management, LP is based out at New York, NY

Below you can find more details about Athyrium Capital Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $3.2 Million
Healthcare: $3.2 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$125M
$3.2 Million 100.0% of portfolio
1,256,411
Q1 2024 Reduced 29.89%
Biora Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q4 2023 Added 545.02%

Summary

  • Portfolio
  • No. of Stocks 2
  • Current Value $3.2 Million
  • Prior Value $4.1 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 12, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Athyrium Capital Management, LP Portfolio

Follow Athyrium Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athyrium Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athyrium Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email